Current Research in Translational Medicine

Papers
(The TQCC of Current Research in Translational Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Machine learning and artificial intelligence in the service of medicine: Necessity or potentiality?53
Thoughts on cartilage tissue engineering: A 21st century perspective36
CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges28
Role of Nrf2 in rheumatoid arthritis28
A common TMPRSS2 variant has a protective effect against severe COVID-1926
Mechanistic insights into the role of pyroptosis in rheumatoid arthritis26
Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine22
Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials21
Human mesenchymal stromal cells from different tissues exhibit unique responses to different inflammatory stimuli20
Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation17
Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy16
Extracellular vesicles isolated from mesenchymal stromal cells primed with neurotrophic factors and signaling modifiers as potential therapeutics for neurodegenerative diseases15
A review of potential treatments to date in COVID-19 patients according to the stage of the disease15
Heparin beyond anti-coagulation15
Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease15
Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy14
Role and mechanism of LAIR-1 in the development of autoimmune diseases, tumors, and malaria: A review13
COVID-19 paraclinical diagnostic tools: Updates and future trends12
Clinical prognosis evaluation of COVID-19 patients: An interpretable hybrid machine learning approach11
European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party10
Astaxanthin attenuates acute cerebral infarction via Nrf-2/HO-1 pathway in rats10
IFNG-AS1 and MAF4 long non-coding RNAs are upregulated in acute leukemia patients who underwent bone marrow transplantation10
Cell therapy for prenatal repair of myelomeningocele: A systematic review10
Identification of serum exosomal miR-98–5p, miR-183–5p, miR-323–3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms8
Preclinical study of a DNA vaccine targeting SARS-CoV-28
Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or “just” a marker of bacterial coinfection?8
Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease7
Biological responses to COVID-19: Insights from physiological and blood biomarker profiles7
Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin7
CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review7
Clinical determinants of relapse following CAR-T therapy for hematologic malignancies: Coupling active strategies to overcome therapeutic limitations7
Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial7
Understanding the hematopoietic microenvironment in chronic myeloid leukemia: A concise review6
Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection6
In silico assessment of binding affinities of three dementia-protective Human Leukocyte Antigen (HLA) alleles to nine human herpes virus antigens6
The use of intrathecal chemotherapy and dexamethasone for secondary prevention of blinatumomab-related neurotoxicity6
In utero treatment of myelomeningocele with allogenic umbilical cord-derived mesenchymal stromal cells in an ovine model6
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia6
Comparison of mouse, rat and rabbit models for adipose - Derived stem cells (ASC) research5
Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death5
PHF19 inhibition as a therapeutic target in multiple myeloma5
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans5
Cryopreserved allogeneic mesenchymal stem cells enhance wound repair in full thickness skin wound model and cattle clinical teat injuries5
A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER25
0.017526865005493